The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11026 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Anagnostis, P., Karagiannis A., Tziomalos K., Kakafika A. I., Athyros V. G., & Mikhailidis D. P. (2009).  Adrenal incidentaloma: a diagnostic challenge.. Hormones (Athens). 8(3), 163-84.
Anagnostis, P., Bosdou J. K., Kenanidis E., Potoupnis M., Tsiridis E., & Goulis D. G. (2020).  Vitamin D supplementation and fracture risk: Evidence for a U-shaped effect.. Maturitas. 141, 63-70.
Anagnostis, P., Karras S. N., Vakalopoulou S., & Terpos E. (2016).  Haemophilia and low bone mass. Ok, but what about fracture risk?. Haemophilia. 22(1), 11-4.
Anagnostis, P., Paschou S. A., & Goulis D. G. (2018).  Management of Acute Hip Fracture.. N Engl J Med. 378(10), 971-2.
Anagnostis, P., Siolos P., Christou K., Gkekas N. K., Kosmidou N., Athyros V. G., et al. (2018).  The effect of antidiabetic medications on the cardiovascular system: a critical appraisal of current data.. Hormones (Athens). 17(1), 83-95.
Anagnostis, P., Karagiannis A., Tziomalos K., Athyros V. G., Kita M., & Mikhailidis D. P. (2010).  Endocrine hypertension: diagnosis and management of a complex clinical entity.. Curr Vasc Pharmacol. 8(5), 646-60.
Anagnostis, P., Paschou S. A., Kenanidis E., Lambrinoudaki I., Potoupnis M., Tsiridis E., et al. (2019).  "Holidays" for osteoporosis drugs: A case-based approach.. Case Rep Womens Health. 23, e00127.
Anagnostis, P., Papanikolaou D., Ioannidou P. G., Bosdou J. K., Mikhailidis D. P., Hatzimouratidis K., et al. (2021).  The effect of statins on semen parameters in patients with hypercholesterolemia: A systematic review.. Andrology. 9(5), 1504-1511.
Anagnostis, P., Vakalopoulou S., Karras S., Charizopoulou M., & Garipidou V. (2014).  The role of arthropathy in the development of osteoporosis in patients with haemophilia: do we need more?. Haemophilia. 20(1), e83-5.
Anagnostis, P., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Impact of statins on glucose metabolism--a matter of debate.. Am J Cardiol. 107(12), 1866.
Anagnostis, P., Paschou S. A., Gkekas N. N., Artzouchaltzi A-M., Christou K., Stogiannou D., et al. (2018).  Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review.. Endocrine. 60(3), 373-383.
Anagnostis, P., Karras S. N., Athyros V. G., Mikhailidis D. P., & Karagiannis A. (2014).  Subclinical Cushing's syndrome and cardiovascular disease.. Lancet Diabetes Endocrinol. 2(5), 361.
Anagnostis, P., Katsiki N., Adamidou F., Athyros V. G., Karagiannis A., Kita M., et al. (2013).  11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?. Metabolism. 62(1), 21-33.
Anagnostis, P., Efstathiadou Z., Polyzos S. A., Tsolakidou K., Litsas I. D., Panagiotou A., et al. (2010).  Long term follow-up of patients with adrenal incidentalomas--a single center experience and review of the literature.. Exp Clin Endocrinol Diabetes. 118(9), 610-6.
Anagnostis, P., Vaitsi K., Mintziori G., Goulis D. G., & Mikhailidis D. P. (2020).  Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia.. Curr Med Res Opin. 1-10.
Anagnostis, P., & Goulis D. G. (2019).  Letter to the Editor: "Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease".. J Clin Endocrinol Metab. 104(8), 3124.
Anagnostis, P., Christou K., Artzouchaltzi A-M., Gkekas N. K., Kosmidou N., Siolos P., et al. (2019).  Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis.. Eur J Endocrinol. 180(1), 41-50.
Anagnostis, P., & Goulis D. G. (2020).  Cushing's Syndrome and Cardiovascular Risk.. Curr Vasc Pharmacol. 18(1), 25-26.
Anagnostis, P., Karras S., Lambrinoudaki I., Stevenson J. C., & Goulis D. G. (2016).  Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options.. Int J Clin Pract. 70(12), 967-977.
Anagnostis, P., Vakalopoulou S., Charizopoulou M., Kazantzidou E., Chrysopoulou T., Moka E., et al. (2013).  Is there any association between leptin levels and bone mineral density in haemophiliac men?. Arch Med Sci. 9(3), 459-65.
Anagnostis, P., Athyros V. G., Adamidou F., Florentin M., & Karagiannis A. (2010).  Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?. Curr Vasc Pharmacol. 8(5), 720-30.
Anagnostis, P., Florou P., Bosdou J. K., Grimbizis G. F., Iakovou I., Kolibianakis E. M., et al. (2021).  Decline in anti-Müllerian hormone concentrations following radioactive iodine treatment in women with differentiated thyroid cancer: A systematic review and meta-analysis.. Maturitas. 148, 40-45.
Anagnostis, P., Paschou S. A., & Goulis D. G. (2018).  Calcium and Vitamin D Supplements and Fractures in Community-Dwelling Adults.. JAMA. 319(19), 2041.
Anagnostis, P., Bosdou J. K., Vaitsi K., Goulis D. G., & Lambrinoudaki I. (2020).  Estrogen and bones after menopause: a reappraisal of data and future perspectives.. Hormones (Athens).
Anagnostis, P., Vakalopoulou S., Slavakis A., Simoulidou E., Rakitzi P., Garipidou V., et al. (2009).  Hypoglycemia in a patient with advanced Sezary syndrome.. Leuk Lymphoma. 50(2), 284-6.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.